Pitchkit
VC
United Kingdom
In The News Oct 2026

Abingworth

Check Size
€14M – €28M
Outreach
Cold Email OK

Investment Focus

Geographic Focus

Europe
United States
Global

Investment Thesis

Transatlantic life sciences investor (est. 1973, acquired by Carlyle 2022) backing seed through late-stage therapeutics. 75 IPOs and 49 M&As from 190+ companies.

How to Pitch Abingworth

Cold Email Works
Abingworth is open to unsolicited pitches. A short, specific email is the fastest way in.

Who To Contact

Andrew Sinclair
Managing Director, Head of Publics & Late Stage
Jayson Punwani
Managing Director, Head of Venture
Source

Portfolio Highlights

Vaxcyte - US pneumococcal vaccine biotech (Nasdaq: PCVX); Abingworth led Series A
Sierra Oncology - myelofibrosis biotech acquired by GSK for $1.9B
Alnylam Pharmaceuticals - RNAi therapeutics pioneer; Abingworth early-stage investor

Team

Auto-detected from Abingworth's website.

Andrew Sinclair
Managing Director, Head of Publics & Late Stage
Source
Checked Sept 2026
Ankur Shah
Vice President, CCD
Source
Checked Sept 2026
Bali Muralidhar
Global Head of Life Sciences & CIO
Source
Checked Sept 2026
Diya Malhotra
Principal
Source
Checked Sept 2026
Graham Mills
Principal
Source
Checked Sept 2026
Jayson Punwani
Managing Director, Head of Venture
Source
Checked Sept 2026
Kurt von Emster
Managing Partner
Source
Checked Sept 2026
Robert DeBenedetto
Managing Director, CCD
Source
Checked Sept 2026
Ron Hsu
Principal
Source
Checked Sept 2026
Travis Wilson
Managing Director, CCD
Source
Checked Sept 2026

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Abingworth?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.

Check Your Fit With AbingworthDraft an Email to Abingworth

Contact

www.abingworth.com

More Investors in United Kingdom

20VC215024Haymarket6 Degrees CapitalView All in United Kingdom

Guides

Biotech Pitch GuideSeed Fundraising GuideFundraising in United KingdomWhat Investors Look For

More Biotech Investors

Simpact VenturesBrandon Capital PartnersCriteria Capital RiscLU InnovationView All Biotech Investors
Check Your Fit With Abingworth